Johnson & Johnson adds to AAA (abdominal aortic aneurysms) range with TERAMed purchase
This article was originally published in Clinica
Executive Summary
Johnson & Johnson company Cordis is to buy private company TERAMed to gain access to its catheter-based system for the treatment of abdominal aortic aneurysms (AAAs). The new technology will complement Cordis Endovascular's range of products, Cordis says.